Ephrin-B2 is a transmembrane protein that binds to Eph receptors on adjacent cells, leading to bidirectional signaling. This signaling can be divided into two types:
Ephrin-B2 binds promiscuously to several Eph receptors, including EPHA4, EPHA3, and EPHB4. This interaction is essential for cell migration, repulsion, and adhesion, which are critical for the proper formation of tissues and organs .
Ephrin-B2 plays a pivotal role in the development of the cardiovascular system. It is involved in heart morphogenesis and the regulation of cell adhesion and migration. Ephrin-B2, along with its receptor EPHB4, is crucial for angiogenesis, the process by which new blood vessels form from pre-existing vessels. This process is vital for supplying oxygen and nutrients to tissues during development and in response to injury .
Recombinant human Ephrin-B2 is a laboratory-produced version of the protein, often used in research to study its functions and interactions. It is typically expressed in HEK 293 cells and purified to high levels of purity, making it suitable for various applications such as SDS-PAGE, ELISA, and Western blotting .
Recombinant human Ephrin-B2 is used in various research applications to understand its role in development and disease. It is particularly valuable in studying cardiovascular diseases, cancer progression, and neurodegenerative diseases. By understanding how Ephrin-B2 interacts with its receptors and other cellular components, researchers can develop potential therapeutic strategies for these conditions .